Gross Margin

CFO Martin Fischer's reappointment secures leadership continuity, reinforcing Fresenius Medical Care's focus on financial discipline and long-term growth.

Two iconic American brands partner to reclaim the spritz, blending Michigan cider and California bubbly for a new patriotic cocktail celebrating 250 years.

As Michigan homeowners face steep premium hikes, a new tech-driven insurer arrives, offering a data-centric model for agents and consumers.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

Following a record year of profit and growth, the French diagnostics firm secures a major analyst endorsement, signaling a powerful turnaround. What's next?

With revenue hitting a record $47.6M, TerraCycle proves sustainability is profitable. But as it raises millions, can it overcome greenwashing critiques?

NextNRG reports a 56% revenue surge driven by AI-optimized fueling, but a closer look reveals a high-stakes bet on future energy infrastructure.

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

Newly public Yesway faces its first major test with its Q1 earnings. Investors will scrutinize if its aggressive expansion can meet high analyst expectations.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

Hesai Group posts another profitable quarter and a major Mercedes-Benz deal, while unveiling a strategic pivot from hardware to a 'Physical AI' ecosystem.

Nearly 40% of skin care sales will be online by 2030, powered by AI. Discover how algorithms are the new beauty counter and what it means for you.

EMS, backed by Wynnchurch Capital, acquires a key rival, signaling a strategic consolidation push in the booming U.S. aluminum distribution market.

Record heat and soaring energy costs are straining wallets. New 'drop-in' heat pumps offer an affordable, high-efficiency upgrade without a major renovation.

A new bispecific antibody, TRIV-573, enters clinical trials, targeting both skin barrier and inflammation to redefine atopic dermatitis therapy.

Amid tourism recovery and new delivery laws, NUGL reports strong Q1 earnings, signaling a new era for Jamaica's burgeoning regulated cannabis industry.

Alarum Technologies will report Q1 results on May 28. Investors are watching to see if massive AI investments are fueling sustainable growth or just costs.

The footwear giant exceeded Q1 expectations, boosting its full-year profit outlook on the back of double-digit growth from its star athletic brands.

With 799% revenue growth and major Fortune 10 deals, Energous proves wireless power is no longer a gadget gimmick but essential industrial tech.

The 2026 Chandler Index reveals a paradox: government performance is up, but a staggering 70% of nations are fiscally weaker than five years ago.